Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice-Reference-Cited by-同舟云学术

Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice

Published:2013-12 Issue: Volume:39 Page:153-157
ISSN:0161-813X
Container-title:NeuroToxicology
language:en
Short-container-title:NeuroToxicology

Author:

Crowley James J.^ORCID,Ashraf-Khorassani Mehdi,Castagnoli Neal,Sullivan Patrick F.^ORCID

Publisher

Elsevier BV

Subject

Toxicology,General Neuroscience

Reference36 articles.

1. Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate?;Avent;Life Sci,1997

2. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies;Bloomquist;J Pharmacol Exp Ther,1994

3. Neuroleptic medications inhibit complex I of the electron transport chain;Burkhardt;Ann Neurol,1993

4. The diversity outbred mouse population;Churchill;Mamm Genome,2012

5. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature;Crane;Am J Psychiatry,1968

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Icariin attenuates dopaminergic neural loss in haloperidol-induced Parkinsonism in rats via GSK-3β and tyrosine hydroxylase regulation mechanism;Journal of Chemical Neuroanatomy;2024-03

2. Utility of phenolic acids in neurological disorders;Advancement of Phenolic Acids in Drug Discovery;2024

3. Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study;Frontiers in Pharmacology;2023-03-03

4. Antipsychotic Agents;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

5. Converging dopaminergic neurotoxicity mechanisms of antipsychotics, methamphetamine and levodopa;EUR REV MED PHARMACO;2021